Background-The purpose of this study was to develop a long-term model to predict mortality after percutaneous coronary intervention in both patients with ST-segment elevation myocardial infarction and those with more stable coronary disease. 
(ASCERT) project represents a unique collaboration among 2 professional societies and an academic research organization (the Duke Clinical Research Institute). The project has been funded by the National Heart, Lung, and Blood Institute to study the comparative effectiveness of PCI versus coronary artery bypass graft surgery. 3 The clinical databases in ASCERT are composed of the American College of Cardiology Foundation National Cardiovascular Data Registry (NCDR) CathPCI Registry and the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 4 Long-term follow-up data are provided by linking these clinical databases to the Centers for Medicaid and Medicare Services (CMS) 100% denominator file. 5 The present study uses the linked CathPCI Registry/CMS database to examine the longitudinal outcomes of patients aged Ն65 years for up to 3 years after PCI.
Methods
The CathPCI Registry is an initiative of the American College of Cardiology Foundation and the Society for Cardiovascular Angiography and Interventions. The CathPCI Registry includes 2 001 529 PCI records from patients discharged between 2004 and 2009 from 1032 participating hospitals (Figure 1 ). 5 Patients aged Ն65 years who underwent PCI between 2004 and 2007, with data in the American College of Cardiology-NCDR version 3 data set, were linked to CMS claims files with a probabilistic matching algorithm that overcomes the need for a universal patient identifier. 5 The establishment of this CMS-registry link then permitted the identification of patients in common with the CathPCI Registry.
The NCDR has several mechanisms in place to ensure data quality, including electronic data capture by hospitals with the use of a certified data collection tool, automated checks of submitted data for completeness, and an annual on-site audit program that involves reviewing charts at a select number of sites to ensure data accuracy. A professional audit, independent of the NCDR, reported a 93% median agreement between hospital records and data submitted to the CathPCI Registry in 2010.
Records in these 2 databases were considered to refer to the same patient if they matched on a set of indirect identifiers including patient date of birth and sex, hospital name, admission date, and discharge date. The matching algorithm required an exact match on some of these variables and a partial match on several variables. Once the individual patient records were linked, longitudinal records were created containing follow-up information, such as subsequent death and all subsequent hospitalizations, as a unified record. Follow-up for mortality was available for all patients until December 31, 2007. This project was approved by the American College of Cardiology Foundation's independent institutional review board Chesapeake Research Review, Inc, as well as the institutional review boards of Duke University and Christiana Care Health System.
Data Analysis
Candidate variables (25 total) were selected from the CathPCI Registry. All preprocedural variables from the diagnostic catheterization and PCI database version 3.0 were considered. 6 Glomerular filtration rate was estimated according to the Modified Diet and Renal Disease equation. 7 The number of diseased vessels was derived from variables in the CathPCI Registry, with Ն70% diameter stenosis for the left anterior descending, right coronary, circumflex, and ramus coronary arteries and saphenous vein or arterial bypass grafts used to define significant obstruction, except for the left main coronary artery, for which Ͼ50% diameter stenosis was considered significant. Subgroups of interest were defined in advance and included gender, age Յ75 and Ͼ75 years, diabetes mellitus, chronic kidney disease, number of coronary arteries diseased, left ventricular function defined by ejection fraction, chronic lung disease, and peripheral vascular disease. Data are displayed as proportions or meanϮSD. The models were based on variables available at the start of the PCI procedure; thus, procedural details and complications were not included.
The study sample was stratified by the presence or absence of ST-segment elevation myocardial infarction (STEMI) at admission, and each group was randomly divided into 60% derivation and 40% validation cohorts. The development sample was used to determine the form of the model and estimate regression coefficients. Data from the validation sample were used to assess model discrimination and calibration.
Predictors of mortality were determined by Cox model analysis. 8 Variables were included in the final model for clinical relevance and/or if they contributed to the model significantly (the 95% confidence interval of the hazard ratio did not include 1) in at least 1 of the periods in at least 1 group, STEMI or without STEMI. We used cubic spline plots to explore the functional form of continuous variables. For each continuous variable, we found that its effect on the log-hazard of mortality was approximately linear below a threshold and approximately constant above the same threshold. On the basis of these exploratory analyses, ejection fraction was modeled as linear Ͻ60% and constant Ͼ60%. Body mass index was modeled as linear Ͻ30 kg/m 2 and constant Ͼ30 kg/m 2 . We found that patients with glomerular filtration rate Յ30 mL/min per 1.73 m 2 had risk similar to that of dialysis patients. Therefore, dialysis and glomerular filtration rate Յ30 mL/min per 1.73 m 2 were combined into a single "renal failure" category. For patients without renal failure, the effect of glomerular filtration rate was modeled as linear between 30 and 70 mL/min per 1.73 m 2 and as constant at Ͼ70 mL/min per 1.73 m 2 . The goal of the study was to produce a predictive model, potentially including covariates for which the hazard ratios varied over time. A single model incorporating "time-dependent covariates," however, would have resulted in a model that depended on continuous time parameters and would not have led to a straightforward presentation of results. Therefore, to investigate the proportional hazards assumption and to simplify the modeling and presentation of results, a discrete mechanism was constructed to reflect these calculations in reasonable intervals. Hazard ratios for all variables were assessed separately for the following time periods: from the day of the procedure to 1 month, 1 to 12 months, and Ͼ12 months. These time periods were selected to account for periprocedural, midterm, and longer-term mortality. To account for withinhospital clustering, 95% confidence intervals were computed with the use of sandwich standard error estimates. 9 As expected, several variables demonstrated evident differences in hazard ratios over the 3 time periods. Final variables were kept in the models on the basis of whether they demonstrated significant interactions over the time intervals or contributed significantly within an interval. The final model was constructed by first including all of these variables in Cox proportional hazards models for each of the 3 intervals. Because each subsequent interval is conditional on survival in the previous one, we combined the models together to compute unconditional probabilities of survival from procedure to 3 years after PCI. Mathematically, this was equivalent to fitting a single Cox model with piecewise constant hazard ratios for all model variables.
Separate models were created for patients undergoing primary PCI for STEMI and for all other patients (the without-STEMI group). The decision to create separate models was based on the different pathophysiological and clinical circumstances of primary PCI as well as the considerably higher mortality in these patients. In each model, interactions were examined by identifying 5 predictors with the highest global 2 statistics and creating all possible pairwise interactions among them. Although some interaction terms were statistically significant, measures of model calibration and discrimination were not materially affected by their inclusion, and models without interactions were considered to be substantially more interpretable and usable. Therefore, models with only main effects were presented.
Predictor data were highly complete, with most covariates having Յ1% missing data. An exception was ejection fraction (missing 28%), which was modeled separately with an indicator variable for missing values. This approach was adopted because failure to measure ejection fraction may be a proxy for unmeasured patient baseline characteristics that are potentially informative for the purpose of predicting the patient's subsequent risk of death. For all other variables, missing categorical variables were imputed to the most common value, and missing continuous variables were imputed to relevant group-specific medians to improve prediction of missing values.
Finally, model calibration and discrimination were evaluated in the 40% validation sample. Predicted survival curves were generated by applying regression estimates from the development sample to covariate data from the validation sample. To assess calibration graphically, the average model-predicted survival probabilities among patients in the validation sample were plotted as a function of time and compared with nonparametric (Kaplan-Meier) survival estimates, overall and for each subgroup of interest. Model-based and nonparametric estimates of 1-year mortality risk were compared across deciles of model-based estimated 1-year risk. Finally, model discrimination was assessed with the use of Harrell's C statistic, which represents the probability that among 2 randomly selected patients, the patient who survived longer had a lower predicted risk of mortality. 10 The C statistic was estimated separately for survival up to 30 days and at 1, 2, and 3 years. However, results were very similar, and we report only 2-year C indices, overall and for each subgroup of interest. SAS (version 9.2; SAS Institute, Cary, NC) and R (version 2.13.0) statistical software were used for all statistical testing. Table I in the online-only Data Supplement). Because of uncertainty about the date of death, 30 additional patients were excluded from the final data set for analysis, resulting in a final study population of 343 466.
Results

Among
The 343 466 patients in the study population were randomly divided into a derivation cohort with 206 081 patients (60%) and a validation cohort with 137 385 patients (40%). Patient characteristics overall, in the STEMI and in the without-STEMI study populations of the derivation cohort, are displayed in Table 1 . Overall, these groups are representative of patients undergoing PCI except that the study population was limited to those aged Ն65 years. The mean age of our study population was 75 years, and the majority of patients were white. The mean body mass index was within the overweight range, and just under half never smoked. Diabetes mellitus was present in a substantial minority, and the majority had hypertension. Prior revascularization was common. A history of heart failure was noted in a minority, and comorbidities were common. Mean ejection fraction was Ͻ0.50 for STEMI patients and Ͼ0.50 for the without-STEMI group. Although multivessel disease was common, left main disease was found in a small minority of patients. Within the without-STEMI group, most cases were elective or urgent, whereas most cases of STEMI were emergent or salvage.
Median follow-up was 15 months from the index procedure. Mortality is summarized in Table 2 . Of the 206 081 Table 3 . The 30-day, 1-year, and 2-year C indices in the validation data set were 0.78, 0.79, and 0.79 for STEMI and 0.76, 0.78, and 0.78 for the without-STEMI models, respectively. The hazard ratios and 95% confidence intervals are shown for each group at Ͻ1 month, 1 to 12 months, and Ͼ12 months. In general, the 95% confidence intervals were relatively small because of the size of the study population. Many variables were predictive, although few had large hazard ratios. Predictive variables include demographics, comorbidity, prior procedures, severity of illness, and urgency of presentation. Variables related to anatomic severity of disease, such as ejection fraction and left main disease, or to severity of disease at presentation, such as cardiogenic shock, were relatively powerful predictors of mortality. Some variables, such as age, had relatively constant hazard ratios across the time periods. Others, such as male sex, were initially neutral or associated with decreased risk but showed increased risk over time. Some, such as prior valve surgery, were unstable because of low numbers of patients. Finally, variables associated with the acuteness of the presentation, such as cardiogenic shock, portended increased risk during the first month but not in the long term.
Calibration of the model in the validation population is presented in Figure 2 , with observed and predicted risk displayed across the spectrum of risk from Ͻ5% to Ͼ70% risk in patients with STEMI ( Figure 2A ) and from Ϸ2% to 40% in patients without STEMI ( Figure 2B ). The observed and predicted risks were almost identical up to 20% predicted mortality; above this range, mortality risk was underestimated to some extent. Survival curves for both STEMI and without-STEMI groups in the validation population are displayed in Figure 3 , with slight underprediction of mortality in the STEMI patients ( Figure 3A ) and with observed and predicted curves being nearly identical for patients without STEMI ( Figure 3B ). Note that there is significantly higher initial mortality with STEMI than without STEMI, accounting for most of the difference in survival by 1000 days. Observed and predicted survival rates in subgroups of those with STEMI and without STEMI in the validation population are displayed in Figures 4 and 5 . There was a difference in survival for all subgroups except by sex. The observed and predicted survival rates are quite similar in subgroups with larger sample sizes but vary somewhat from the predicted rates in STEMI subgroups with smaller sample sizes.
Discussion
By linking the CathPCI Registry to the CMS 100% denominator file, we have developed prediction models for survival for up to 3 years after PCI in a data set of 343 466 patients aged Ն65 years. The large size of the study population has resulted in narrow 95% confidence intervals for both estimates of survival and hazard ratios. The variables observed to be predictive of mortality included demographics, comorbidity, severity of disease, and acuteness of presentation. Acuteness of presentation is most predictive early in follow-up, whereas older age, comorbidity, and severity of disease are more predictive over the longer term. The models had excellent C indices for long-term models as well as nearly perfect calibration. Restriction of the study population to patients aged Ն65 years removes much of the influence of age on outcome and thus leads to a lower C index than would be observed in the larger data set. Furthermore, the observed and predicted survival curves and estimated risk by decile in the validation data set almost completely overlapped until 3 years of follow-up both in the overall cohort and within multiple subgroups.
Previous Predictive Models
The models that we have developed are consistent with those developed previously from the NCDR for in-hospital mortality. 1, 2, 11 Variables that predict mortality generally include demographics, comorbidities, severity of disease, and acuteness of presentation. Variables reflecting acuteness at presentation generally have the largest hazard ratios. In-hospital models generally calibrate well and have high C indices as a measure of discrimination. By linking the NCDR CathPCI Registry to the CMS 100% denominator file, Curtis et al 12 created models to predict 30-day mortality in patients with STEMI and in all other patients using data from patients undergoing PCI in 2006. Acuteness of presentation was the strongest predictor in both models. The models had both good discrimination (C index of 0.83 for the STEMI/shock model and 0.82 for the non-STEMI/nonshock model) and calibration. Validation of these models was performed by reanalysis in the group undergoing PCI in 2005.
A number of models have also been developed with the use of other databases from the Society for Cardiac Angiography and Intervention, 13 Northern New England, 14 Michigan, 15 Washington State, 16 and New York State, 17 as well as single-site databases 18 -20 to predict in-hospital mortality and complications after PCI. Most models included demographic variables, comorbidity, disease severity, and acuteness of clinical presentation.
Several long-term models have also been developed. Addala et al 21 developed a risk score for long-term mortality after primary intervention in acute myocardial infarctions using pooled data from the Primary Angiography in MI (PAMI) trials. MacKenzie et al 22 developed models to predict death long-term after PCI using data from the Northern New England database, with data on PCIs from 1992 through 2001. There were 19 806 patients with mortality data obtained from the National Death Index. Data were divided into follow-up periods of 0 to 91 days, 4 to 18 months, and Ͼ18 months, with C indices of 0.83, 0.78, and 0.76, respectively. Calibration was excellent. Correlates of mortality included demographics, comorbidity, severity of disease, and acuteness of clinical presentation. The observed predictors were similar to those in the present study. For instance, the hazard ratio was Ͻ1.0 for male sex in the short term but Ͼ1.0 in the longer term. A history of diabetes mellitus, heart failure, or kidney disease and decreased ejection fraction increased risk STEMI indicates ST-segment elevation myocardial infarction; HR, hazard ratio; CI, confidence interval; BMI, body mass index; MI, myocardial infarction; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; GFR, glomerular filtration rate; NYHA, New York Heart Association; EF, ejection fraction; and IABP, intra-aortic balloon pump.
during all time periods. Emergent procedures increased risk primarily in the short term.
The model we present in this article is by far the largest to date for the long-term mortality outcome of PCI. With combination of the clinical and angiographic predictors of NCDR with the outcomes collected by CMS, this is a unique collaboration, combining 2 databases of unquestioned authority. This model offers the best available prediction tool for the Medicare population. This model can therefore be utilized by clinicians and payers to evaluate the likely outcomes of PCI in this population, supplementing clinical judgment. Moreover, the results are based on contemporary data from the period when drug-eluting stents were used. The size of the data set permits remarkably high precision in the estimates of hazard ratios and expected survival. The models have been evaluated thoroughly for discrimination, calibration, and validation. The data set also comes from 791 sites all over the United States, making it the most representative and generalizable of its kind. Previous models using the NCDR were limited to in-hospital results and, more recently, 30-day outcomes. 2, 12 Short-term models are clearly limited when compared with long-term models in predicting outcome.
The present study is based on linkage of the CathPCI Registry to the CMS 100% denominator file, which is an 
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Long-Term Mortality After PCI 1507 administrative database. Covariate information related to comorbidity, severity of disease, and acuteness of presentation is limited in such an administrative database. [23] [24] [25] Linkage of clinical and administrative databases offers the more accurate assessment of clinical covariates along with the availability of long-term outcome data. Probabilistic matching offers an approach to link the databases without patient identifiers, which can resolve both Health Insurance Portability and Accountability Act and informed consent limitations. Careful institutional review board approval is clearly needed for such projects.
Clinical Implications
The present model will be available to CathPCI Registry participants and through the ASCERT Web site to aid in individual risk assessment. The model, however, is directly applicable only in patients who have had the procedure. There is added uncertainty when such models are used to compare outcomes of several alternative therapeutic choices because this assumes that the patients being considered for alternative approaches would be fully described by the variables considered in the model. Alternative treatments are best considered in the context of randomized trials or carefully conducted observational studies. Such methods, however, cannot consider specific patient characteristics, which may best be accounted for with the use of risk models such as the one presented here. Thus, the ability to assess risk for each patient can aid in decision making. This study has a number of limitations. The model is only as good as the quality of the data. Furthermore, a number of the data elements, of which several are related to acuteness of the procedure, are relatively subjective and have relatively high hazard ratios. Hospitals are aware that coding of such variables can affect benchmarking of their outcomes, which might potentially lead to preferential coding bias. All variables, however, are carefully defined, and an audit process is in place to verify the data. The study may not represent all hospitals because some hospitals do not participate in the CathPCI Registry. It is, however, the most representative national database of outcomes after PCI. The CathPCI Registry has only limited angiographic data and limited data related to severity of ischemia, both of which may limit the ability of these models to predict outcome. More detailed anatomic data, such as those derived from the SYNTAX score, may enhance the model. 26, 27 Finally, the results of this analysis can be applied only to patients aged Ն65 years. In conclusion, we have developed a long-term mortality model after PCI based on the largest data set to date, using contemporary data from the CathPCI Registry and long-term outcome data from the CMS 100% denominator file. This model may be used to predict mortality of patients undergoing PCI and may aid in medical decision making. Future studies will consider models that include nonfatal outcomes and cost. It may also be possible to investigate the impact of such models on medical decision making and outcomes. These models may also help to inform the design of future clinical trials concerning revascularization strategies. This study did not require any new data collection, and thus the model can be updated or extended relatively easily. This model, as well as future models based on these methods, will permit physicians and patients to estimate prognosis with considerable precision both initially and during follow-up after a procedure or event. 
CLINICAL PERSPECTIVE
Most survival prediction models for percutaneous coronary intervention are limited to in-hospital end points. Although short-term mortality rates remain low, multiple stakeholders, including providers, patients, and payers, will be more interested in long-term survival. We linked the broadly representative, real-world clinical data from the American College of Cardiology-National Cardiovascular Data Registry CathPCI Registry with vital statistics from the Medicare 100% denominator file to construct a robust, long-term percutaneous coronary intervention survival prediction model. This study included 343 466 patients aged Ն65 years who underwent percutaneous coronary intervention either with or without ST-segment elevation myocardial infarction between 2004 and 2007. Median follow-up was 15 months, with mortality of 2.97% at 30 days, and 8.58%, 13.4%, and 18.3% at 1, 2, and 3 years, respectively. Twenty-four demographic and clinical comorbidities, prior history of disease, and indices of disease severity and acuity were identified as being associated with mortality. Discrimination, calibration, and validation of the model were all excellent. The large sample size permitted precise estimates of the influence of clinical correlates on survival. Early mortality is predicted by variables related to acuteness of presentation, whereas longer-term mortality is associated with chronic debilitating diseases such as insulin-dependent diabetes mellitus and dialysis-dependent renal failure and behaviors such as cigarette smoking. The model may be used for shared medical decision making, quality improvement, and provider benchmarking and as a basis for developing comparative effectiveness research. 
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